Longevity News

Pig kidneys just bought humans extra years in eGenesis study

Source: Longevity Technology • Published: 04 Sept 2026, 17:24

Pig kidneys just bought humans extra years in eGenesis study

Genetically engineered pig kidneys as a bridge therapy for people with kidney failure; a news feature that explains the study approach and patient implications.

Key Takeaways
  • Five patients received the engineered pig kidney EGEN-2784 under expanded access in the study
  • Three patients maintained kidney function for more than eight months without dialysis
  • Two patients later received human donor kidneys after initial xenotransplantation success
Read Original Source

Continue exploring

Related longevity signals

Longevity TechnologyAI hunts new uses for Phase 3 metabolic drugAn AI-driven reverse‑engineering approach mines existing pharmacology and gene expression data to reveal additional disease targets for a late‑stage metabolic drug.Longevity TechnologyFractyl Health’s Revita data show lasting weight lossThis article previews a clinical update on an endoscopic procedure aimed at sustaining GLP-1–related weight loss, with context on company milestones and next-step data.Longevity TechnologyGreenstone bets on human cells to fix DMD heartsA biotech-focused article on a federally backed human-cell and AI drug-discovery approach for Duchenne cardiomyopathy, highlighting its potential to replace animal models and accelerate orphan-disease programs.Longevity TechnologyClaremedica’s digital test finds 90% of new dementia cases earlyA report on a primary care group’s adoption of a digital cognitive assessment and what readers will learn about its implementation and uptake.